Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Globus Medical Affirms FY2025 Adj EPS Guidance of $3.00-$3.30 vs $3.16 Est; Affirms FY2025 Sales Guidance of $2.800B-$2.900B vs $2.852B Est

Author: Benzinga Newsdesk | August 07, 2025 03:17pm
Globus Medical (NYSE:GMED) affirms FY2025 Adj EPS guidance from $3.00-$3.30 to $3.00-$3.30 vs $3.16 analyst estimate. Affirms FY2025 sales outlook from $2.800 billion-$2.900 billion to $2.800 billion-$2.900 billion vs $2.852 billion estimate.

Posted In: GMED


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist